Dr. Marco Quarta, Ph.D. - Co-Founder and CEO - Rubedo Life Sciences; Discovering And Developing Medicines To Keep You Biologically Young episode artwork

EPISODE · Sep 22, 2023 · 1H 5M

Dr. Marco Quarta, Ph.D. - Co-Founder and CEO - Rubedo Life Sciences; Discovering And Developing Medicines To Keep You Biologically Young

from Progress, Potential, and Possibilities Podcast / Show · host Ira Pastor / Dr. Marco Quarta

Send us Fan MailDr. Marco Quarta, Ph.D. is Co-Founder and CEO of Rubedo Life Sciences ( https://www.rubedolife.com/ ), a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The company's proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders. Dr. Quarta received his doctorate degree in Biotechnology from the University of Bologna and a Ph.D. in Neuroscience from the University of Padua. He completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University and continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital in Palo Alto, CA. While there, he established a translational program in regenerative medicine. He has over 35 publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation. Dr. Quarta also co-founded Wetware Concepts, Young European Biotech Network (YEBN), and Turn Biotechnology, and served as an executive board member of the European Federation of Biotechnologies. He currently sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) Calpoly Bridge program, and the advisory board at the Center for Healthcare Innovation. He is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University, one of the most prestigious institutions supporting the science of aging. Dr. Quarta also serves as CEO and President for the Board of Directors of The Phaedon Institute ( https://www.phaedon.institute/ ), a think-tank organization that operates with the mission of supporting and enabling effective and sustainable growth in the field of aging and longevity sciences. Support the show

Episode metadata supplied by the publisher feed · Published Sep 22, 2023

Embed this episode

Send us Fan Mail Dr. Marco Quarta, Ph.D. is Co-Founder and CEO of Rubedo Life Sciences ( https://www.rubedolife.com/ ), a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The company's proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatologica...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Dr. Marco Quarta, Ph.D. - Co-Founder and CEO - Rubedo Life Sciences; Discovering And Developing Medicines To Keep You Biologically Young

0:00 1:05:17

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Progress, Potential, and Possibilities Podcast / Show?

This episode is 1 hour and 5 minutes long.

When was this Progress, Potential, and Possibilities Podcast / Show episode published?

This episode was published on September 22, 2023.

Can I download this Progress, Potential, and Possibilities Podcast / Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!